Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENT OF CASH FLOWS

v3.21.2
CONDENSED STATEMENT OF CASH FLOWS
 9 Months Ended
Sep. 30, 2021
USD ($)
Cash flows from operating activities  
Net loss $ (2,871,225)
Adjustments to reconcile net loss to net cash used in operating activities  
Formation cost paid by the Sponsor in exchange for issuance of the Founder Shares 5,000
Interest income on investments held in the Trust Account (5,316)
Transaction costs allocated to the Warrants 208,936
Change in fair value of warrant liability 1,898,329
Changes in operating assets and liabilities  
Prepaid expenses (795,102)
Accrued expenses 194,238
Net cash used in operating activities (1,365,140)
Cash flows from investing activities  
Investment of cash in the Trust Account (155,250,000)
Net cash used in investing activities (155,250,000)
Cash flows from financing activities  
Proceeds from sale of the Units, net of underwriting discounts paid 152,145,000
Proceeds from sale of the Private Placement Warrants 6,105,000
Repayment of the Promissory Note—related party (43,101)
Payment of offering costs (381,575)
Net cash provided by financing activities 157,825,324
Net change in cash 1,210,184
Cash—beginning of period 0
Cash—end of period 1,210,184
Non-cash investing and financing activities  
Offering costs paid by the Sponsor in exchange for issuance of the Founder Shares 20,000
Offering costs paid through the Promissory Note 43,101
Deferred underwriting fee payable $ 5,433,750